Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. - Wikidata - awgldk - TriplyDB

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

http://www.wikidata.org/entity/Q42077769

about

Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling Pramipexole-induced disruption of behavioral processes fundamental to intertemporal choice.Impulsive and compulsive behaviors in Parkinson's disease Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.Imaging insights into basal ganglia function, Parkinson's disease, and dystonia Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's disease Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.Management of impulse control disorders in Parkinson's disease: Controversies and future approaches Pathological gambling in Parkinson's disease: what are the risk factors and what is the role of impulsivity?Affective disorders in Parkinson's disease.Dopamine receptor mapping with PET imaging in Parkinson's disease.Uncovering the role of the insula in non-motor symptoms of Parkinson's disease.Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.Dopamine Agonists and Impulse Control Disorders: A Complex Association.Neuroimaging in Parkinson's disease: a future perspective.Medial prefrontal cortex lesions impair decision-making on a rodent gambling task: reversal by D1 receptor antagonist administration.Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients Liking, wanting, and the incentive-sensitization theory of addiction.Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD.Update on Molecular Imaging in Parkinson's Disease.Imaging behavioural complications of Parkinson's disease.The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.Differences in trait impulsivity do not bias the response to pharmacological drug challenge in the rat five-choice serial reaction time task.Positron emission tomography in Parkinson's disease: insights into impulsivity.Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.Impulse Control Behaviors in Parkinson's Disease: Drugs or Disease? Contribution From Imaging Studies Evolving Concepts of Emotion and Motivation

P2860

Q26776152-6EC2EBB9-73B5-4FC9-9476-1583637B5C02 Q28290596-0960BD29-DF92-4892-B15C-C1AA38EBFB99 Q30301190-00AAA8C7-5758-4863-A10F-9B866FC67B1D Q31158920-08691C83-AA6F-4E0B-8F60-C05BA1772604 Q33652554-F64FC602-8B93-4998-813C-5E8C0E15C70D Q33687660-B352D8E9-F768-4140-93FC-8C746D251566 Q34165153-1A9DB618-6F46-433F-A159-D55752ABEBEC Q34342432-B0A660D2-9D53-4E75-97D5-4C864BC222F8 Q34423280-6B2BB406-10D8-4FED-BFF1-C30A2EF92E06 Q35054558-BCE6D065-91DE-43D8-8250-F7FA87F361A1 Q35193033-A39EA28F-803F-4A75-A318-04C872C87662 Q35674375-4D7C1FA5-6DF6-407B-859C-D51758956655 Q36641307-182EF74C-251D-4D7F-BB34-8D3C1B90FE1D Q36724965-7A6CD978-E5AF-4F97-8987-24A0EC63A47F Q36994341-C546DF84-6AC6-447F-86E2-63B472BDFF36 Q37361959-C7A16AC3-287A-48A7-BF9C-A7A35BEC3AD2 Q37561079-C4B81312-878D-49B6-A71B-A4E2D838E373 Q38113755-F0EF37D8-A915-4EA1-8390-635C4A368013 Q38195788-C829BA32-865A-4A0E-A9D7-50B03DB0803E Q38204871-A82575F5-73B7-4C3C-B07B-3FEE09A2CDC0 Q38419501-A4554325-3E8B-479C-BCC9-47BEBA508676 Q38571789-17DB9715-0FAC-488C-BCAA-CFBD006EE499 Q38588201-0D162D53-6EEA-49DF-AFDD-BD498237E9BD Q38598331-FC046038-C827-4111-BA12-5AF61F0C7A6F Q39015987-D81A626D-A2EF-43B9-82A8-CDEF80B6DF7C Q40007882-0F306E70-CD8B-4E64-93E4-F43B3B6062A8 Q40930752-68051F4F-0991-40CA-9236-512131A22EDC Q42035690-75DC92C5-2DC0-49F6-99CF-E673B3C5A043 Q42907401-F20248E1-0916-4BC1-93D0-5AC7DC7F0061 Q43101572-01E081E0-A295-434B-8F7E-97BD393846A5 Q47250613-08C263F6-D604-4ABD-A23C-699B763F04C0 Q47633386-3B81293A-0D94-477D-8A4D-B13F0B8BC827 Q47830362-3022CBA2-B02E-473F-8921-9729F47C8F6D Q48085068-1B94A46D-1D38-4FEF-BA60-519115F1D216 Q49646040-845F3939-7908-44A8-B1AE-21E5E8BA4A93 Q50069106-60046046-8AC0-4DF9-9253-3ADCE8D54A4B Q52315876-0B88405A-CBFF-43F9-B011-8BE33432BF64 Q58556476-3A4216BB-4470-4CC5-9A18-FB1BA26030B7 Q58758941-C8B72C5F-2B7B-4B30-90BB-3B7CBCD311AF

P2860

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

http://www.wikidata.org/entity/Q42077769

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study.

@en

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study.

@nl

type

label

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study.

@en

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study.

@nl

prefLabel

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study.

@en

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study.

@nl

P1433

Q42077769-5A6D8C5C-0B3B-41C3-A282-B1F25EE73A05

P1476

Q42077769-B0C08683-3D71-4F10-9E83-1964B0CFDE93

P2093

Q42077769-9BEC82BF-A256-4D76-B3FF-4BFC30A3EA95

Q42077769-BA1B594C-F4D0-4312-9053-295936B02E29

Q42077769-EA720223-06B4-42D0-A9B9-2038F54E8491

Q42077769-ED8C1A98-F345-4A50-8887-B9233D3F4C95

P2860

Q42077769-014E6FEE-8D68-4464-A689-A7C71D72302B

Q42077769-0900D84A-5FD8-4E0D-ABB2-2FBDB0FD8955

Q42077769-0B737888-2EDD-49DA-BDF3-A6263D8C8B10

Q42077769-0F7A1FEE-0B1E-4D1B-84E0-7D0244FE2ACB

Q42077769-14EF2346-F3FC-4354-B98B-C5E1E95C2CEB

Q42077769-192A11EF-0E3B-488F-B948-271360BC7EE0

Q42077769-1A0AC477-9382-4E0D-8879-D2D81604EF67

Q42077769-1AAD0AEA-6211-4860-87BC-6A468479E56E

Q42077769-1B06B928-7FA0-4719-97B7-95823F30D237

Q42077769-1C152753-FB47-45C4-A0CD-97E9D2939858

P304

Q42077769-1C9D85B9-95D9-4642-A802-89CFC87A7DDF

P31

Q42077769-B3BF19D4-AC0F-41C6-A26D-405D76C83F18

P356

Q42077769-4AD23067-9C9B-46E2-9395-797FCC8BFEC7

P433

Q42077769-2ECA007C-5D3E-4B63-A157-7ECF1F0D3311

P478

Q42077769-6B0F8089-C999-4642-AA90-869567856B82

P50

Q42077769-09ECAD29-1712-4BC6-B036-9673BE1750D5

Q42077769-5AFB009B-5CE1-479B-BB41-63D457BA8E65

Q42077769-97775C98-5973-4141-91B2-18594F551C35

Q42077769-9BC7EA0B-ECC6-44FF-AD62-2C5702A24B7F

Q42077769-C72BC149-ACDA-4DE2-A055-98A146E70419

Q42077769-FDFC87DE-C5AF-4BE0-BBFA-101D8741C75A

P577

Q42077769-F3C0FB73-B7B0-4A54-8D47-9DBE30F62880

P5875

Q42077769-E277BD59-CB41-4712-BDE8-207D8CCF2607

P698

Q42077769-875D5D68-E6D1-4873-825E-A4D6A2EE90B9

P921

Q42077769-C5FCC910-CA14-4013-A209-4E3C09C6443C

Q42077769-ECAD42A1-2612-4AA5-88A9-1BF071BE7F96

P932

Q42077769-80330A43-79AA-4A39-AFD0-0715E10A900A

P356

J.NBD.2012.06.021

P1433

Neurobiology of Disease

P1476

Extrastriatal dopaminergic abn ...... a [11C] FLB-457 and PET study

@en

P2093

Antonio P Strafella

http://www.w3.org/2001/XMLSchema#string

Francesca Antonelli

http://www.w3.org/2001/XMLSchema#string

Giovanna Pellecchia

http://www.w3.org/2001/XMLSchema#string

Sang Soo Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor

Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity

Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings

Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.

Factor structure of the Barratt impulsiveness scale

Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task.

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

P304

519-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2012.06.021

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Janis M. Miyasaki

Mateusz Zurowski

P577

2012-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228329862

http://www.w3.org/2001/XMLSchema#string

P698

22766031

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3465363

http://www.w3.org/2001/XMLSchema#string